Beta blockers have been proposed to increase the risk of developing PD, whereas beta agonists have been suggested as protective, possibly through proposed up- and down-regulation of SNCA expression, respectively34,35, although some population-based studies have failed to show this correlation36. This evidence concerns the gene SNCA and Parkinson disease.